Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Blohm

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|June 1, 1972
Hypocholesterolemic indole-2-carboxylic acidsT Kariya, J M Grisar, N L Wiech, et al.
Journal of Medicinal Chemistry|June 1, 1973
Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregationC H Tilford, R D MacKenzie, T R Blohm, et al.
Biochemical and Biophysical Research Communications|August 15, 1989
17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase)M R Angelastro, M E Laughlin, G L Schatzman, et al.
Biochemical and Biophysical Research Communications|July 16, 1980
Inhibition of testosterone 5 alpha-reductase by a proposed enzyme-activated, active site-directed inhibitorT R Blohm, B W Metcalf, M E Laughlin, et al.
Journal of Medicinal Chemistry|December 1, 1972
Naphthylalkyl lactamimides as inhibitors of blood platelet aggregationE M Roberts, J M Grisar, R D MacKenzie, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1981
Toxicity and teratogenicity studies with the hypolipidemic drug RMI 14,514 in ratsJ P Gibson, E J Larson, J T Yarrington, et al.
Endocrinology|September 1, 1986
Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effectsT R Blohm, M E Laughlin, H D Benson, et al.
Journal of Medicinal Chemistry|December 1, 1972
Treloxinate and related hypolipidemic 12H-dibenzo(d,g)(1,3)dioxocin-6-carboxylate derivativesJ M Grisar, R A Parker, T Kariya, et al.
The Prostate|January 1, 1993
LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male ratsB L Neubauer, K L Best, T R Blohm, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|June 1, 1972
Hypocholesterolemic indole-2-carboxylic acidsT Kariya, J M Grisar, N L Wiech, et al.
Journal of Medicinal Chemistry|June 1, 1973
Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregationC H Tilford, R D MacKenzie, T R Blohm, et al.
Biochemical and Biophysical Research Communications|August 15, 1989
17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase)M R Angelastro, M E Laughlin, G L Schatzman, et al.
Biochemical and Biophysical Research Communications|July 16, 1980
Inhibition of testosterone 5 alpha-reductase by a proposed enzyme-activated, active site-directed inhibitorT R Blohm, B W Metcalf, M E Laughlin, et al.
Journal of Medicinal Chemistry|December 1, 1972
Naphthylalkyl lactamimides as inhibitors of blood platelet aggregationE M Roberts, J M Grisar, R D MacKenzie, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1981
Toxicity and teratogenicity studies with the hypolipidemic drug RMI 14,514 in ratsJ P Gibson, E J Larson, J T Yarrington, et al.
Endocrinology|September 1, 1986
Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effectsT R Blohm, M E Laughlin, H D Benson, et al.
Journal of Medicinal Chemistry|December 1, 1972
Treloxinate and related hypolipidemic 12H-dibenzo(d,g)(1,3)dioxocin-6-carboxylate derivativesJ M Grisar, R A Parker, T Kariya, et al.
The Prostate|January 1, 1993
LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male ratsB L Neubauer, K L Best, T R Blohm, et al.
Pageof 2